Le Lézard
Classified in: Health, Business, Sports and recreation
Subject: LIC

Team Novo Nordisk partner with Santic Clothing for 2023


Team Novo Nordisk is racing in Santic clothing during the 2023 season.

ATLANTA, Nov. 23, 2022 /PRNewswire-PRWeb/ -- Team Novo Nordisk is proud to announce Santic as the team's new clothing partner for 2023 and beyond with the Asian company providing both performance and technical wear for the world's first all-diabetes professional cycling team.

"We are very happy to have a partner with the experience of Santic coming on board," said General Manager Vassili Davidenko. "Their company goals align with ours as a team to continue to expand our platform and be able to further inspire, educate and empower everyone affected by diabetes around the world by racing and competing at the highest level of professional cycling with a technical partner at the cutting edge of performance athletic apparel."

"As a professional cyclist who spends hundreds of hours in the saddle over thousands of kilometers each year, one of the most important things is your clothing. You need to be aerodynamic, protected from the elements and above all you need to be comfortable, and Santic can give our riders everything they need to be able to perform at their maximum."

Formed in China in 2005, Santic is an international sports manufacturing and global industrial trade group with a complete supply chain management system, keeping the product in-house all the way from design and production to delivery. A well-established company that supplies trending, bulk production, and in-store solutions for technical sportswear. After 17 years of development, it has become a global industrial and trade group and currently has more than three thousand employees worldwide.

With high performance cycling apparel continuing to be a key part of Santic's story, the Chinese brand is excited to be working with Team Novo Nordisk and becoming a part of the world's first all diabetes professional cycling team's unique and meaningful community.

"We are touched by Team Novo Nordisk's amazing work to try to help and inspire all those affected by diabetes," said Fred Hou, CEO of Santic Group. "Luckily, we now have a chance to start our partnership with the team and be part of that work. Team Novo Nordisk is the world's first all-diabetes pro cycling team where the riders race and compete against the world's best pro cyclists."

"We are delighted that we can join the team to help reshape what it means for people to live with diabetes. Together with the team, we believe that we can develop our products to be combined with comfort and performance to the next level."

To learn more about Santic, please visit: https://santic.com/

----

About Team Novo Nordisk ? Racing to Drive Change in Diabetes

Team Novo Nordisk is a global all-diabetes sports team of cyclists spearheaded by the world's first all-diabetes professional cycling team. In 2012, Phil Southerland, co-founder and CEO of the team, and global healthcare company Novo Nordisk, came together to create Team Novo Nordisk, based on a shared vision to inspire, educate, and empower people around the world affected by diabetes and promote a healthy and active lifestyle.

For more information, go to http://www.teamnovonordisk.com.

Media Contact

Tim Lindley, Team Novo Nordisk, +39 3911106499, [email protected]

 

SOURCE Team Novo Nordisk


These press releases may also interest you

at 20:31
Fitness International, LLC opened a new Club Studio location in Kingwood, Texas. The new 40,000 square foot club features five innovative boutique fitness studios that were carefully curated to create a unique experience, along with recovery services...

at 19:35
Mirum Pharmaceuticals, Inc. today announced that on May 10, 2024, the Compensation Committee of Mirum's Board of Directors granted inducement awards consisting of non-qualified stock options to purchase 38,600 shares of common stock and 19,300...

at 19:00
Evolus, Inc. , a performance beauty company with a focus on building an aesthetic portfolio of consumer brands, today reported the grant of non-qualified stock options to purchase an aggregate of 10,990 shares of Evolus and an aggregate of 42,759...

at 18:36
Inhibrx, Inc. ("Inhibrx," or the "Company") today announced that in connection with the previously announced distribution by the Company of 92% of shares of common stock of its subsidiary Inhibrx Biosciences, Inc. ("SpinCo") to holders of shares of...

at 17:55
Asia Green Biotechnology Corp. ("Asia Green" or the "Company") announces that, further to its news releases dated April 17, 2024, April 26, 2024, and May 8, 2024, the Management Cease Trade Order ("MCTO") issued by the...

at 17:53
The following statement is being issued by Rice Harbut Elliott LLP regarding the Ruckman v. Biotrade Canada Ltd. et al. lawsuit: All persons in Canada who purchased or ingested U-Dream on or after August 18, 2014 (the "Class" or "Class Members")...



News published on and distributed by: